Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.01%), DAX30 (0.12%), CAC40 +0.03%

Mar 07 ,2024

  • Synopsis

    • European equity futures are little changed amidst mixed session in Asia and higher close on Wall Street overnight. US futures softer. Bonds narrowly mixed. US 10-year yield steady at 4.11%. Dollar softer with biggest move versus yen. Oil up. Gold firmer. Industrial metals mixed.

    • Focus today will be on ECB interest rate decision at 14:15CET, press conf 14:45. No change in benchmark interest rate is expected. Also, latest ECB staff macroeconomic projections will be released with likely downward revision to growth and inflation forecast. In other events, BOE's Benford speech at 14:00GMT at the Big Data & AI World conf and Bundesbank's Balz speech at 16:00CET. Also today, heads of government of the German states are meeting in Berlin. The afternoon meeting includes Chancellor Scholz, and will focus on migration and refugee policy. A post meeting press conf is scheduled. UK MPs continue debate on the Spring Budget. EU's Simson delivers a keynote speech and participates in a panel discussion at the Offshore Norge's Annual Conf.

    • In macro releases, Germany Jan factory orders and manufacturing turnover are due at 7:00 GMT, along with Norway Jan manufacturing production, Denmark Jan manufacturing production and UK Feb house price index - Halifax. Switzerland Feb Unemployment Rate (sa) came in at 2.2% and in line with consensus 2.2% and prior 2.2%.

    • Another busy morning for earnings and trading updates. Of note, out of DACHs, Hugo Boss (BOSS.GR) reported final FY numbers with Q4 EPS €1.23 vs FactSet €1.08 and confirmed previously reported sales and EBIT; group guides 2024 EBIT of €430-475M vs FactSet €492.24M. Continental (CON.GR) reports FY net income €1.16B vs consensus €1.41B and revenue €41.42B vs guidance €41-43B. Merck KGaA (MRK.GR) reports FY EPS pre one-time items €8.49 vs FactSet €8.40 and expects return to organic growth in 2024. In France, JCDecaux (DEC.FP) reports netter-than-expected FY net income at €209M vs FactSet €149.3M whilst EBIT a miss at €266.2M vs FactSet €274.0M; group also proposes no dividend to be paid in 2024 in order to preserve financial flexibility. Eurazeo (RF.FP) reports FY results with Assets Under Management (AUM): +9% y/y to €35B and launches new €200M share buyback program for 2024.

  • Macro/Politics/ World News:

    • ECB set to keep borrowing costs steady for a fourth meeting but forecasts to boost case for rate cuts - Bloomberg

    • EU conservatives set to endorse von der Leyen as bloc's next chief executive - Reuters

    • UK:

      • VAT threshold for UK businesses limited by EU rules, Hunt admits privately - The Guardian

      • Budget fell far short on UK green investment, experts say - The Guardian

      • UK Is 'On Track' for 4% Hit to Economy From Brexit, OBR Says - Bloomberg

    • French budget squeeze has only just begun - Reuters

    • Ukraine:

      • Explosions hit Odesa as Zelensky meets Greek PM - BBC

      • Senior Russian officer warns Ukraine conflict could escalate into full-scale war in Europe - Reuters

  • Top company news

    • Earnings/updates

      • CON.GR (Continental) -- FY net income €1.16B vs consensus €1.41B; hikes di by ~47% and guides FY24

      • ZAG.AV (Zumtobel Group) -- Q3 net income €0.3M vs year-ago €9.7M; confirms FY outlook

      • DEC.FP (JCDecaux) -- FY net income €209M vs FactSet €149.3M [10 est, €123.1-212.7M]

      • BOSS.GR (Hugo Boss) -- Q4 EPS €1.23 vs FactSet €1.08; guides 2024 EBIT of €430-475M vs FactSet €492.24M

      • G1A.GR (GEA Group) -- FY EPS €2.56 ex-items vs consensus €2.30

      • NEXI.IM (Nexi SpA) -- FY normalized net income €711.8M vs FactSet €726.1M; To proposes up to €500M share buy-back program; guides 2024

      • MRK.GR (Merck KGaA) -- FY EPS pre one-time items €8.49 vs FactSet €8.40 [15 est, €7.93-8.68]; expects return to organic growth in 2024

      • PSM.GR (ProSiebenSat.1 Media) -- final FY adj net income €260M vs FactSet €213.2M; confirms FY24 outlook

      • PBB.GR (Deutsche Pfandbriefbank) -- FY pretax income €90M vs preliminary €90M and FactSet €91.6M

      • RF.FP (Eurazeo) -- FY net income €1.82B vs FactSet €299.2M [3 est, €108.1-500M]

      • TIT.IM (Telecom Italia) -- board approves 2024-2026 "Free to Run" industrial plan

      • UCG.IM (UniCredit) -- moves the date of the board approval of Q1 results to 6-May from 29-Apr

      • AVOL.SW (Avolta) -- FY core EPS CHF2.21 vs FactSet CHF2.29 [12 est, CHF1.90-3.50]

      • GLJ.GR (GRENKE) -- FY EPS €1.79 vs FactSet €1.78 [5 est, €1.76-1.79]; confirms forecast for 2024

      • NFN.GR (NFON) -- FY adj EBITDA €8.4M vs year-ago (€1.0M)

      • CTPNV.NA (CTP NV) -- Q4 EPRA EPS €0.19 vs year-ago €0.16

      • TEP.FP (Teleperformance) -- FY net income €602M vs FactSet €798.9M [16 est, €613.5-917M]; proposed dividend of €3.85/sh

      • CGG.FP (CGG) -- final FY earnings inline with prelim. release: Adj. EBITDA $400M vs guidance $390-400M

      • JMT.PL (Jeronimo Martins) -- FY net income attributable €756M, raises dividend +21.6% y/y (post EU close 6-Mar)

      • BANB.SW (Bachem Holding) -- FY net income CHF111.9M vs FactSet CHF106.5M [8 est, CHF100.9-110.9M]; div +6.7% y/y

      • SPIE.FP (SPIE) -- FY adjusted net income €344.0M vs FactSet €337.1M [8 est, €314-353.9M]

      • ELIS.FP (Elis) -- FY headline net income €433.4M vs FactSet €414.7M; hikes divi by 5% and guides FY24

      • VIJ.GR (Viemed Healthcare) -- Q4 EPS $0.09 vs year-ago $0.06

      • AZE.BB (Azelis Group) -- FY adj EBITA €466.3M vs FactSet €472.6M

      • KARN.SW (Kardex Holding) -- FY net income €66.9M vs FactSet €60.1M [2 est, €59.1-61.1M]

      • SFSN.SW (SFS Group) -- FY net income CHF268.5M vs FactSet CHF269.4M [8 est, CHF258.5-280.8M]

      • HAUTO.NO (Höegh Autoliners) -- Feb trading update: transported 1.1M CBM of cargo on prorated basis

      • MTU.FP (Manitou BF) -- FY EPS €3.75 vs year-ago €1.43

    • M&A

      • ROVI.SM (Laboratorios Farmaceuticos Rovi, S.A.) -- has engaged Lazard to assess potential strategic alternatives

      • ECV.GR (Encavis AG) -- confirms talks on potential transaction with KKR (KKR);

      • +SCH.GR (Schenker) -- Deutsche Bahn targeting Schenker sale in H2 of 2024 - Reuters

    • Healthcare

      • PFE (Pfizer) -- FDA approves sNDA for Besponsa of treatment of relapsed or refractory CD22-positive B-cel ALL in pediatric patients 1 year and older

      • DXCM (Dexcom) -- trading sharply higher; analysts see no surprises from Roche presentation at ATTD

      • BAYN.GR (Bayer AG) -- Bayer confirms there is zero chance of a fresh capital increase - FT

      • ZLAB (ZAI Lab) -- to present final overall survival (OS) data from Phase 3 NORA study of ZEJULA (niraparib) in platinum-sensitive recurrent ovarian Cancer (PSROC)

      • FRE.GR (Fresenius) -- FDA approves Fresenius' Tyenne, second biosimilar of Actemra

      • VIJ.GR (Viemed Healthcare) -- SEC filing: 10-K

    • Other

      • VETN.SW (Vetropack Group) -- starts consultation process on the future of its production site in St-Prex; could result in its closure this year

      • MTG.SW (Meier Tobler Group) -- replaces the ongoing share buyback program with a buyback offer at a fixed price

      • STLAM.IM (Stellantis) -- announces €5.6B investment in South America from 2025 to 2030

      • BA.LN (BAE Systems) -- awarded $181.9M US Navy contract modification for ACV program

      • MKS.LN (Marks & Spencer Group) -- Marks & Spencer co-CEO Katie Bickerstaffe to step down this year to pursue portfolio career - Sky News

      • AVOL.SW (Avolta) -- publishes 2023 ESG report

      • ECV.GR (Encavis AG) -- signs two non-recourse project refinancing agreements in total amount of €203M for its operating solar plants Talayuela and La Cabrera, Spain

      • EURN.BB (Euronav) -- Index Change: Euronav NV to be included in BEL 20 Index

      • ELIOR.FP (Elior Group) -- discloses terms of share buyback progam

      • TPEIR.GA (Piraeus Financial Holdings) -- Hellenic Financial Stability Fund sets offering of Piraeus Financial Holdings shares at €4.00/share - Reuters (6-Mar, 16:32 CET)

      • MMT.FP (M6-Metropole) -- announces free streaming platform, M6+

  • Key rating changes

    • Upgrades

      • AAL.LN (Anglo American) -- to overweight from equal-weight at Morgan Stanley

      • ACE.IM (ACEA) -- to outperform from neutral at Mediobanca

      • ADYEN.NA (Adyen) -- to outperform from neutral at BNP Paribas Exane

      • ATCO.A.SS (Atlas Copco) -- to equal weight from underweight at Barclays

      • DOM.LN (Domino's Pizza Group) -- to buy from add at Peel Hunt

      • EDPR.PL (EDP Renovaveis) -- to buy from hold at Bestinver Securities

      • IBE.SM (Iberdrola) -- to overweight from equal-weight at Morgan Stanley

      • LMP.LN (LondonMetric Property) -- to buy from hold at Berenberg

      • SIGN.SW (SIG Combibloc Group) -- to equal weight from underweight at Barclays

    • Downgrades

      • BAYN.GR (Bayer AG) -- to market perform from outperform at Bernstein

      • GTT.FP (Gaztransport & Technigaz) -- to hold from buy at Berenberg

      • INTRUM.SS (Intrum) -- to sell from hold at Arctic Securities

      • MONC.IM (Moncler) -- to market perform from outperform at Bernstein

      • PIRC.IM (Pirelli & C.) -- to neutral from outperform at BNP Paribas Exane

      • PIRC.IM (Pirelli & C.) -- to hold from buy at Kepler Cheuvreux

      • SAVE.SS (Nordnet) -- to hold from buy at SEB

      • UNI.SM (Unicaja Banco) -- to hold from buy at Jefferies

    • Initiations

      • LONN.SW (Lonza Group) -- outperform at Oddo

      • SCA.B.SS (Svenska Cellulosa) -- underweight at Barclays

      • STERV.FH (Stora Enso) -- underweight at Barclays

  • Data

    • Nikkei (1.23%) to 39598.71

    • Hang Seng (1.26%) to 16230.55

    • Shanghai Composite (0.38%) to 3028.43

    • S&P futures (9.8) vs prior close of 5111.8

    • €-$ +0.0002 or +0.02% to 1.0899

    • $-¥ (1.19) or (0.80%) to 148.20

    • €-¥ (1.32) or (0.81%) to 161.51

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE